Literature DB >> 6493582

Late sequelae after meningococcal disease. A controlled study in young men.

J Sander, D Bay, T W Gedde-Dahl, H M Borchgrevink, L O Frøholm, S I Oftedal, B Vandvik.   

Abstract

The occurrence of sequelae 3-15 years after meningococcal disease has been investigated in a study on 71 patients and 64 controls. The patients were young men, aged 18 to 24 years at the time the disease was contracted. Participants filled in a questionnaire on possible symptoms. Audiometry and EEG were also carried out. The response rates were 84% among patients and 75% among controls. We found that 61% of the patients had one or more symptoms of possible sequelae compared to 20% in the control group (p less than 0.001). The symptoms were generally light and of mental or neurological type. Among the patients 13% stated that they had obvious complaints commonly attributed to meningococcal disease, compared to 2% only in the controls (p less than 0.05). Twenty-nine per cent of the patients stated that the disease had affected their education or working capacity. No statistical differences between patients and controls were demonstrated by audiological or EEG examinations. In only one single ear could deafness unequivocally be attributed to the disease.

Entities:  

Mesh:

Year:  1984        PMID: 6493582

Source DB:  PubMed          Journal:  NIPH Ann        ISSN: 0332-5652


  5 in total

1.  Should college students be vaccinated against meningococcal disease? A cost-benefit analysis.

Authors:  L A Jackson; A Schuchat; R D Gorsky; J D Wenger
Journal:  Am J Public Health       Date:  1995-06       Impact factor: 9.308

2.  Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules.

Authors:  Manish Sadarangani; Tim Sell; Mildred A Iro; Matthew D Snape; Merryn Voysey; Adam Finn; Paul T Heath; Gianni Bona; Susanna Esposito; Javier Diez-Domingo; Roman Prymula; Adefowope Odueyungbo; Daniela Toneatto; Andrew J Pollard
Journal:  CMAJ       Date:  2017-10-16       Impact factor: 8.262

3.  Neurodevelopmental outcome in meningococcal disease: a case-control study.

Authors:  J M Fellick; J A Sills; O Marzouk; C A Hart; R W Cooke; A P Thomson
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

Review 4.  Meningococcal vaccination in pregnancy.

Authors:  Bahaa Abu Raya; Manish Sadarangani
Journal:  Hum Vaccin Immunother       Date:  2018-03-21       Impact factor: 3.452

5.  AMEND study protocol: a case-control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adults.

Authors:  Helen Marshall; Mark McMillan; Bing Wang; Robert Booy; Hossein Afzali; Jim Buttery; Christopher C Blyth; Peter Richmond; David Shaw; David Gordon; Belinda Barton
Journal:  BMJ Open       Date:  2019-12-29       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.